Avecho Biotechnology Limited (ASX:AVE)
Australia · Delayed Price · Currency is AUD 0.0210
+0.0020 (10.53%)
Aug 21, 2026, 3:56 PM AEST
Avecho Biotechnology Market Cap
Avecho Biotechnology has a market cap or net worth of 81.14 million as of August 21, 2026. Its market cap has increased by 326.13% in one year.
Market Cap
81.14M
Enterprise Value
76.49M
Revenue
1.24M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.02
ChartMarket Cap Chart
Since February 28, 1996, Avecho Biotechnology's market cap has increased from 39.36M to 81.14M, an increase of 106.16%. That is a compound annual growth rate of 2.40%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 81.14M | 145.42% |
| Dec 31, 2025 | 33.06M | 317.27% |
| Dec 31, 2024 | 7.92M | -28.57% |
| Dec 29, 2023 | 11.09M | -59.76% |
| Dec 30, 2022 | 27.57M | 0.10% |
| Dec 30, 2021 | 27.54M | -40.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Recce Pharmaceuticals | 113.80M |
| Alterity Therapeutics | 108.75M |
| Paradigm Biopharmaceuticals | 106.92M |
| LTR Pharma | 86.34M |
| Prescient Therapeutics | 84.12M |
| Amplia Therapeutics | 79.56M |
| Immutep | 78.11M |
| Arovella Therapeutics | 77.36M |